A Cross-sectional, Observational Multicenter Study to Assess the Reasons for Choosing the 3-year Hormonal IUD and Level of IUDs Knowledge Among Women Aged 18 to 29 Years

CompletedOBSERVATIONAL

Enrollment

886

Participants

Timeline

Start Date

September 8, 2016

Primary Completion Date

October 30, 2017

Study Completion Date

December 23, 2017

Conditions

Intrauterine Devices, Medicated

Interventions

DRUG

Levonorgestrel (Jaydess, Skyla, BAY86-5028)

Intrauterine delivery system Jaydess (13.5 mg levonorgestrel)

Trial Locations (1)

Multiple Locations